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ABSTRACT
Message framing is important in health communication research to 
encourage behaviour change. Psoriasis, a long-term inflammatory 
skin condition, has additional comorbidities including high levels of 
anxiety and cardiovascular disease (CVD), making message framing 
particularly important. This experimental study aimed to: (1) identify 
whether health messages about psoriasis presented as either 
gain- or loss-framed were more effective for prompting changes in 
behavioural intentions (BI), (2) examine whether BI were driven by a 
desire to improve psoriasis or reduce CVD risk; (3) examine emotional 
reactions to message frame; and (4) examine predictors of BI. A two 
by two experiment examined the effects on BI of message frame (loss 
vs. gain) and message focus (psoriasis symptom reduction vs. CVD 
risk reduction). Participants with psoriasis (n = 217) were randomly 
allocated to one of four evidence-based health messages related 
to either smoking, alcohol, diet or physical activity, using an online 
questionnaire.  BI was the primary outcome. Analysis of variance 
tests and hierarchical multiple regression analyses were conducted. 
A significant frame by focus interaction was found for BI to reduce 
alcohol intake (p = .023); loss-framed messages were more effective 
for CVD risk reduction information, whilst gain-framed messages were 
more effective for psoriasis symptom reduction information. Message 
framing effects were not found for BI for increased physical activity and 
improving diet. High CVD risk was a significant predictor  of increased 
BI for both alcohol reduction (β = .290, p < .01) and increased physical 
activity (β = −.231, p < .001). Message framing may be an important 
factor to consider depending on the health benefit emphasised  
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(disease symptom reduction or CVD risk reduction) and patient-stated 
priorities. Condition-specific health messages in psoriasis populations 
may increase the likelihood of message effectiveness for alcohol 
reduction.
Introduction
Psoriasis is a complex, long-term, inflammatory skin condition affecting around 2% of the 
population (Parisi et al., 2013). Severe psoriasis has been associated with cardiovascular dis-
ease (CVD) however the independent risk factor for this group is co-morbid inflammatory 
arthritis (Parisi et al., 2015). Of perhaps greater importance is that people with psoriasis are 
more likely to engage in unhealthy behaviours such as excessive alcohol intake, smoking, 
being over-weight and sedentary than those without psoriasis (Hayes & Koo, 2010; Naldi et 
al., 2005; Parisi et al., 2015; Samarasekera et al., 2013). This contributes to psoriasis onset, 
severity, and consequently increases the risk of CVD (National Institute for Health & Care 
Excellence, [NICE], 2010; Yusuf et al., 2004). Despite this, risk factors are often undetected 
(Rutter et al., 2016) or sub-optimally managed (Nelson et al., 2016). People are unaware of 
the links between health behaviours and psoriasis exacerbation, and they do not receive the 
necessary behaviour change support consistent with clinical guidelines (Nelson et al., 2013).
Effective health risk communication methods are crucial for CVD risk reduction (Bonner 
et al., 2014; Keyworth, Nelson, Chew-Graham et al., 2015). Condition-specific informa-
tion may improve risk perceptions and promote more informed decision-making about 
behaviour change (Nelson et al., 2017; Waldron et al., 2011). To date, no studies have 
examined the effectiveness of psoriasis-specific health information in prompting changes 
in behavioural intentions.
Theoretical framework
Message framing theory suggests that message effectiveness is influenced by the type of 
behaviour promoted and the framing of the health message (Rothman et al., 2006). Gain-
frame messages emphasise the benefits of behaviour change (‘quitting smoking lowers your 
risk of lung cancer’), and loss-frame messages emphasise the costs of failure to act (‘by not 
quitting smoking, you increase your risk of lung cancer’). The theory suggests that: (1) 
gain-frame messages are more persuasive for prevention behaviours (‘low risk’ behaviours) 
such as increasing physical activity (Latimer et al., 2008), and (2) loss-frame messages 
are more persuasive for ‘detection’ behaviours (‘high risk’ behaviours) such as promoting 
mammography use (Abood et al., 2005).
However systematic reviews identified inconsistent results (Gallagher & Updegraff, 
2012; O’Keefe & Jensen, 2007, 2009), and other important mechanisms may influence mes-
sage effectiveness. Emotional reactions to health messages may act as a barrier to accurate 
risk perception (Naqvi et al., 2006; Quartz, 2009; Ten Hoor et al., 2012), and self-efficacy, 
an important motivational factor for behaviour change (Armitage & Conner, 2001) may 
increase the impact of risk information on health behaviours (Sheeran et al., 2014).
Considering immediate versus future health consequences is recognised as a central 
characteristic in tailored health communication messages (Morris et al., 2016; O’Connor 
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et al., 2009). Whether an individual is concerned about their immediate health (for example 
their physical appearance), or reducing future health risks (reducing risk of future health 
conditions) is an important area for research in appearance-related conditions. Messages 
tailored around these considerations have been shown to be effective in contexts such as 
skin cancer (Thomas et al., 2011) and safe-sun practices (Aspden et al., 2015). To-date no 
studies have examined whether people with psoriasis are driven to protect their immediate 
health (prevention of psoriasis flares) or their future health (CVD risk).
This exploratory study addressed four specific research questions:
(1)  Are gain- or loss-framed messages more effective for prompting changes in behav-
ioural intentions?
(2)  Are behavioural intentions driven by a desire to improve psoriasis symptoms (i.e. 
immediate consequences; psoriasis skin flare reduction) or reduce CVD risk (i.e. 
reduce long-term health risks; CVD prevention)?
(3)  To what extent do differently framed health messages produce emotional responses?
(4)  What are the predictors are behavioural intentions in people with psoriasis?
Methods
Participants
People with psoriasis were invited to take part in an online questionnaire via advertisements 
placed on a patient organisation website (the Psoriasis Association), a University intranet 
site, in community locations (such as local supermarkets), and through the use of social 
networking websites (Twitter and Facebook). There were no geographical restrictions on 
patient participation. Ethical approval was obtained from the relevant university ethics 
committee (reference: 13118).
Design
A 2 (message frame: loss vs. gain) by 2 (message focus: psoriasis symptom reduction vs. 
CVD risk reduction) between-participants design was used.
Materials
Health messages were constructed using clinical guidelines for CVD (NICE, 2010) and 
psoriasis (NICE, 2012), using information about the effects of health behaviour change on 
either psoriasis symptoms or CVD risk (presented in Figure 1). Using this methodology 
allows for tight experimental control, allowing the researcher to specifically identify which 
messages are effective for prompting behavioural change (de Bruijn et al., 2014; French et 
al., 2004; Wright et al., 2006).
Measures
Intention to follow the advice offered to reduce risk or promote symptom management 
was the primary outcome, measured on a 7-point scale (1–7; possible range 3–21) in line 
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with published recommendations (Ajzen, 1991; Francis et al., 2004). Three items were 
used e.g. ‘I intend to reduce the amount of alcohol I drink in the next month’. Items were 
related to intentions to change the following health behaviours: smoking, alcohol, diet, and 
physical activity. Emotional response was the secondary outcome. Items consisted of two 
items on a 10-point scale (1–10; possible range 2–20), adapted from the literature (French 
et al., 2004; Klein, 1997) e.g. ‘How concerned are you by reading this information?’. Three 
items measured self-efficacy (Armitage & Conner, 2001; Wright et al., 2006) measured on 
a 7-point scale (1–7; possible range 3–21) e.g. ‘How confident are you that you can stop 
smoking in the next month?’
Scenario 1: Gain-frame /CVD risk reduction: 
Research shows that risk factors for cardiova scular disease include smoking, having a poor 
diet, having insufficient physical activity, and drinking excessive amounts of alcohol. By 
making changes to your lifestyle, you [lower] your risk of cardiovascular disease.    
Scenario 2: Loss-frame / CVD risk reduction: 
Research shows that risk factors for cardiova scular disease include smoking, having a poor 
diet, having insufficient physical activity, and drinking excessive amounts of alcohol. By [not] 
making changes to your lifestyle, you [increase] your risk of cardiovascular disease.    
Scenario 3: Gain-frame / psoriasis symptom reduction: 
Research shows that living an unhealthy lifestyle such as smoking, having a poor diet, having 
insufficient physical activity, and drinking excessive amounts of alcohol may contribute to 
skin flare-ups. By making changes to your lifestyle, you [increase] the likelihood of having 
fewer psoriasis flare-ups and healthier looking skin.  
Scenario 4: Loss-frame / psoriasis symptom reduction: 
Research shows that living an unhealthy lifestyle such as smoking, having a poor diet, having 
insufficient physical activity, and drinking excessive amounts of alcohol may contribute to 
skin flare-ups. By [not] making changes to your lifestyle, you [reduce] the likelihood of 
having fewer psoriasis flare-up and healthier looking skin. 
Figure 1. health messages randomly assigned to participants.
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Procedure
Prior to commencement, detailed information about the association between psoriasis, 
CVD and health behaviours was presented on the participant information sheet. Participants 
provided demographic information, current and past severity of psoriasis and were asked 
about their current health behaviours. Participants were informed about recommended 
physical activity levels and units of alcohol according to public health guidelines, and were 
asked to rate whether they met the recommendations (to determine high vs. low risk profile). 
Participants were randomly allocated to read one of the four health messages after which 
they answered the post-message items. The questionnaire was piloted-tested (Dillman, 
2000) with a small convenience sample (n = 16) of members of an established research user 
group of people living with psoriasis.
Sample size and power calculation
In order to test the interaction between the two main effects (message frame: loss vs. gain; 
and message focus: psoriasis symptom reduction vs. CVD risk reduction), a larger than 
is feasible sample size would be required. The study was, therefore, powered to detect a 
standardised difference of 0.5 between the two groups (message frame and message focus) 
defined by a single main effect. As we wanted to test both main effects, an alpha of 2.5% 
was used for the test of each separate main effect, thus maintaining an overall alpha of 5%. 
With 80 participants per main effect (40 per group; 160 in total), the study achieved 80% 
power to detect differences.
Analysis
A series of 2 by 2 analysis of variance tests (ANOVAs) were conducted to investigate the 
main effects of message frame, message focus and the interaction effects on behavioural 
intentions. Hierarchical multiple regression analyses were used to determine the predictors 
of behavioural intentions. Effect sizes were calculated using the means and SDs of each 
experimental group. SPSS v22 was used to conduct the analyses.
At step 1 demographic variables (age and sex) and self-efficacy were added. At step 2 
message frame (gain vs. loss), message focus (psoriasis vs. CVD message) and the frame x 
focus interaction term were added to test for any effect of the wording of health messages 
on behavioural intentions. At step 3 risk category (according to current health behaviour 
profile; high vs. low) was added. The adjusted multiple correlations (R2) measured the pro-
portion of the variation in behavioural intentions predicted by the independent variables. 
Changes in adjusted R2 indicate the amount of variance explained by each step of the model.
Results
The sample (n = 217; Figure 2) was mostly female (58.1%), White British (82%), and reported 
having mild (38.2%), moderate (29.5%) or moderately severe (19.4%) psoriasis (Table 1). 
Descriptive statistics are shown in Table 2. Data are presented for primary variables (behav-
ioural intentions: alcohol, diet, and physical activity) and the secondary variable (emotional 
response to information). Due to the low numbers of smokers (n = 42) included across 
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the four conditions we excluded behavioural intentions related to the smoking in the final 
analysis.
The impact of message frame and message focus on behavioural intentions is presented 
in Table 3. Results are presented in detail according to each outcome measure.
Alcohol behavioural intentions
Neither main effects for message frame [F(1, 159) = 2.08, p = .15] nor message focus [F(1, 
159) = 1.45, p = .23] reached statistical significance.
There was a significant message frame by message focus interaction effect (p =  .023) 
indicating when presented with different messages, there was a difference in reported behav-
ioural intentions based on the message frame and focus. When presented with informa-
tion about psoriasis symptom reduction, reported behavioural intentions were significantly 
higher in the gain-frame condition (mean = 10.56, standard deviation (SD) = 6.30) com-
pared to the loss-frame condition (M = 7.24, SD = 4.56). However, when presented with 
information about CVD risk reduction, reported behavioural intentions were higher in 
Number of participants 
recruited
(n=253)
Number of participants 
randomized
(n=217)
Gain-frame 
CVD risk 
reduction
(n=56)
Gain-frame 
Psoriasis 
symptom 
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Loss-frame 
CVD risk 
reduction
(n=50)
Loss-frame 
Psoriasis 
symptom 
reduction
(n=53)
Drop-outs
(n=36; exited 
online 
questionnaire
pre-
randomization)
Ex
pe
rim
en
ta
l c
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Figure 2. study flow diagram.
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Table 1. demographics of participants randomized.
Variable N (%)
Gender1  
Male 75 (34.6)
Female 126 (58.1)
did not state 16 (7.4)
Age2 M (sd), Range 41.23 (14.31), 15–83
0–19 3 (1.4)
20–39 94 (43.3)
40–59 70 (32.3)
60–79 23 (10.6)
80> 1 (.5)
did not state 20 (9.2)
Ethnicity  
White British 178 (82)
White irish 6 (2.8)
Mixed – White/asian 2 (.9)
asian or asian British –Pakistani 1 (.5)
asian or asian British – indian 5 (2.3)
Melanesian 1 (.5)
Mixed – hispanic european 1 (.5)
White – dutch 1 (.5)
other White 1 (.5)
White european 2 (.9)
Welsh 1 (.5)
chinese 2 (.9)
did not state 26 (12)
Age of Pso diagnosis  
<16 71 (32.7)
16–22 (early onset) 54 (24.9)
23–39 62 (28.6)
40–57 19 (8.8)
57> (late onset) 5 (2.3)
Self-reported Pso severity  
current  
Mild 83 (38.2)
Mild to moderately severe 64 (29.5)
Moderately severe 42 (19.4)
Moderately severe to severe 13 (6)
severe 9 (4.1)
ever  
Mild 18 (8.3)
Mild to moderately severe 24 (11.1)
Moderately severe 49 (22.6)
Moderately severe to severe 70 (32.3)
severe 49 (22.6)
did not state 6 (2.8)
Diagnosis of PsoA 40 (18.4)
Smoker  
ever 113 (52.1)
current 42 (17)
did not state 4 (1.8)
Meeting DOH guidelines for physical activity3  
achieve this every week 86 (39.6)
almost there, but not quite 54 (24.9)
around half of recommended 33 (15.2)
a long way off recommended 41 (18.9)
did not state 3 (1.4)
Typical month, how often do you drink alcohol?  
 never 29 (13.4)
 once a month or less 43 (19.8)
 2 to 4 times a month 66 (30.4)
 2 to 3 times a week 49 (22.6)
 4 or more times a week 28 (12.9)
(Continued)
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the loss-frame condition (M = 10.35, SD = 5.15) compared to the gain-frame condition 
(M = 9.60, SD = 5.33), however the effect size (d = .01) was small.
Diet behavioural intentions
Neither of the main effects were statistically significant [message frame: F(1, 193) = .06, 
p = .80; message focus: F(1, 193) = .97, p = .33], nor was the interaction effect [F(1, 193) = 
.90, p = .34].
Table 1. (Continued).
Variable N (%)
did not state 2 (.9)
Units of alcohol on a typical day  
1–2 49 (22.6)
3–4 66 (30.4)
5–6 32 (14.7)
7–8 20 (9.2)
9+ 21 (9.7)
did not state 29 (13.4)
6 or more units on one occasion  
 never 66 (30.4)
 less than monthly 73 (33.6)
 Monthly 25 (11.5)
 Weekly 38 (17.5)
 daily or almost daily 9 (4.1)
did not state 6 (2.8)
1gender UK psoriasis population characteristics (males 47.7%) according to springate et al. (2017).
2age Psoriasis UK population characteristics (0–19 years [12.1%), 20–39 years [29.6%], 40–59 years [31.4%], 60–79 years 
[22.8%], 80 > years [4%]) according to springate et al. (2017).
3the department of health recommends adults are moderately active for 2 and a half hours or vigorously active for 75 min 
each week. For example 30 min on at least 5 days a week.
Pso = Psoriasis; Psoa = Psoriatic arthritis; doh = department of health.
Table 2. descriptive statistics for all primary and secondary outcome variables.
Variable
M (SD)
Gain-frame   Loss-frame  
Psoriasis 
symptom 
reduction (n 
= 56)
CVD risk 
reduction (n 
= 56) Overall
Psoriasis 
symptom 
reduction (n 
= 52)
CVD risk 
reduction (n 
= 48) Overall
Behavioural 
intentions 
(Alcohol)
10.56 (6.30) 9.60 (5.33) 10.00 (5.74) 7.24 (4.56) 10.35 (5.15) 9.15 (5.13)
Behavioural in-
tentions (Diet)
13.21 (5.37) 13.23 (5.55) 13.22 (5.45) 12.63 (6.04) 14.22 (5.78) 13.53 (5.91)
Behavioural in-
tentions (Physi-
cal activity)
13.87 (5.27) 13.62 (5.71) 13.73 (5.50) 12.97 (5.19) 14.43 (4.89) 13.80 (5.04)
emotional 
response to 
information
8.13 (4.46) 8.47 (5.34) 8.32 (4.95) 7.00 (5.10) 10.16 (4.91) 8.76 (5.21)
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Physical activity behavioural intentions
Neither of the main effects were statistically significant [message frame: F(1, 193) = .00, 
p = .96; message focus: F(1, 193) = .62, p = .43], nor was the interaction effect [F(1, 193) = 
1.23, p = .27].
Emotional response
There was a significant main effect for message focus [F(1, 193) = 5.74, p = .02]; however, the 
effect size was small (d = .03). The main effect for message frame was not statistically signif-
icant [F(1, 193) = .15, p = .70], neither was the interaction effect [F(1, 193) = 3.75, p = .05].
Multiple regression analyses
Results are shown in Table 4 (intentions to reduce alcohol intake), Table 5 (intentions to 
improve diet) and Table 6 (intentions to increase physical activity).
Alcohol
At step 1 neither age, sex nor self-efficacy were independent predictors of intentions to 
reduce alcohol consumption. At step 2 the addition of message frame (β = −6.36, p = .03) 
and the frame x focus interaction (β = .784, p = .04) significantly explained an additional 
.4% of the variance. This indicates that gain-framed messages resulted in higher behavioural 
intentions, for messages about psoriasis symptom reduction, gain-framed messages resulted 
in higher behavioural intentions, and for messages about CVD risk reduction loss-framed 
messages resulted in higher behavioural intentions. Message focus alone did not signifi-
cantly contribute to the variance. In the final regression model (step 3) the addition of risk 
category (β = .290, p ≤ .01) significantly explained 7.6% of the total variance, indicating 
Table 3. Results of anoVa examining effects of message framing and message focus on behavioural 
intentions and emotional responses to health messages.
*significant at the p < .05 level.
Effect df F P Partial n2
Alcohol intention        
Message frame 1 2.081 .151 .013
Message focus 1 1.453 .230 .009
Message frame X message focus interaction 1 5.241 .023* .032
total 163      
Diet intention        
Message frame 1 .062 .804 .000
Message focus 1 .966 .327 .005
Message frame X message focus interaction 1 .903 .343 .005
total 197      
Physical activity intention        
Message frame 1 .003 .956 .000
Message focus 1 .619 .432 .003
Message frame X message focus interaction 1 1.232 .268 .006
total 201      
Emotional response        
Message frame 1 .145 .704 .001
Message focus 1 5.743 .018* .029
Message frame X message focus interaction 1 3.752 .054 .019
total 197      
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that participants identified as high risk (according to self-reported current alcohol intake) 
reported higher behavioural intentions (M = 11.29, SD = 5.40) to reduce alcohol compared 
to those identified as low risk (M = 8.44, SD = 5.32). Message frame (β = −6.08, p = .03) and 
the frame x focus interaction (β = .722, p = .05) remained significant in the final model.
Diet
At step 1, neither age, sex nor self-efficacy were independent predictors of intentions to 
improve participants’ diet. At step 2, the addition of message frame, message focus and frame 
Table 4. Regression model for continuous (age and self-efficacy) and categorical variables on alcohol 
behavioural intentions (n = 165).
*significant at the < .05 level.
Model   R2 ΔR2 β 95%CI p-value
1   .008 −.014      
  age     .049 −.055 to .080 .572
  sex     .054 −1.395 to 2.593 .536
  self-efficacy     .051 −.160 to .289 .554
2   .046 .004      
  age     .056 −.055 to .079 .514
  sex     .035 −1.533 to 2.490 .692
  self-efficacy     .047 −.162 to .284 .581
  Message frame     −.636 −13.506 to −1.072 .027*
  Message focus     −.441 −11.042 to .202 .085
  Frame X focus interaction     .784 .333 to 7.923 .040*
3   .121 .076      
  age     .098 −.042 to .088 .246
  sex     −.014 −2.094 to 1.875 .870
  self-efficacy     .119 −.077 to .369 .164
  Message frame     −.608 −12.874 to −.811 .028*
  Message focus     −.403 −10.478 to .430 .101
  Frame X focus interaction     .722 .079 to 7.448 .049*
  Risk category     .290 1.167 to 5.152 .001*
Table 5. Regression model for continuous (age and self-efficacy) and categorical variables on diet be-
havioural intentions (n = 197).
*model based on n = 36 with BMi data.
Model   R2 ΔR2 β 95% CI p-value
1   .144 .130      
  age     −.261 −.247 to .040 .157
  sex     .046 −3.670 to 4.736 .801
  self-efficacy     .266 −.114 to .808 .142
2   .153 .124      
  age     −.258 −.254 to .049 .185
  sex     .050 −3.950 to 5.109 .799
  self-efficacy     .269 −.137 to .839 .160
  Message frame     −.195 −16.303 to 11.831 .751
  Message focus     −.146 −14.369 to 11.061 .795
  Frame X focus interaction     .313 −6.949 to 10.211 .705
3   .228 .035      
  age     −.291 −.268 to .031 .131
  sex     −.024 −4.918 to 4.261 .902
  self-efficacy     .341 −.044 to .947 .080
  Message frame     −.303 −17.661 to 10.126 .617
  Message focus     −.263 −15.863 to 9.347 .636
  Frame X focus interaction     .376 −6.297 to 10.514 .641
  Risk category*     .314 −.831 to 5.692 .139
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x focus explained no additional variance. At step 3, the addition of risk category (according 
to self-reported BMI) also explained no additional variance in the model.
Physical activity
At step 1, both age (β = −1.77, p ≤ .01) and self-efficacy (β = .587, p ≤ .001) were independ-
ent predictors of intentions to increase physical activity levels and explained 38.7% of the 
variance, indicating that younger participants reported higher behavioural intentions, and 
those with higher self-efficacy reported higher behavioural intentions. At step 2 neither 
the addition of message frame, message focus or frame x focus interaction significantly 
added to the variance. Both age (β = −1.75, p ≤ .01) and self-efficacy (β = .586, p ≤ .001) 
remained significant but accounted for no additional variance. In the final regression model 
(step 3), the addition of risk category (β = −.231, p ≤ .001) explained an additional 5.1% 
of the variance, indicating that participants self- identified as high risk reported higher 
intentions (M = 14.22, SD = 5.20) to reduce alcohol compared to those identified as low 
risk (M = 12.49, SD = 5.34).
Discussion
This is the first study to examine the effects of message framing on reported intentions 
to modify health behaviours in people with psoriasis. There was a small but significant 
interaction between message frame and message focus in the context of alcohol reduction, 
contrary to previous studies. For messages focused on short-term health risk (reducing 
visible psoriasis symptoms), gain-framed messages were more persuasive than loss-framed 
messages in increasing behavioural intentions. Messages about long-term health risk (CVD 
risk reduction) were more persuasive when presented as a loss-framed message rather 
than a gain-framed message. This finding must be interpreted with caution given the small 
Table 6. Regression model for continuous (age and self-efficacy) and categorical variables on physical 
activity behavioural intentions (n = 201).
*significant at the < .05 level.
Model   R2 ΔR2 β 95% CI p-value
1   .397 .387      
  age     −.177 −.113 to −.025 .004*
  sex     .041 −1.092 to 1.465 .49
  self-efficacy     .587 .540 to .796 <.001*
2   .402 .381      
  age     −.175 −.113 to −.024 .004*
  sex     .037 −1.128 to 1.495 .55
  self-efficacy     .586 .536 to .795 <.001*
  Message frame     −.127 −5.631 to 2.530 .51
  Message focus     −.054 −4.695 to 2.681 .760
  Frame X focus interaction     .170 −1.476 to 3.501 .513
3   .454 .432      
  age     −.188 −.117 to −.032 .001*
  sex     .055 −.834 to 1.712 .35
  self-efficacy     .613 .565 to .816 <.001*
  Message frame     −.137 −5.799 to 2.084 .46
  Message focus     −.075 −5.014 to 2.121 .66
  Frame X focus interaction     .195 −1.119 to 3.694 .43
  Risk category     −.231 −3.495 to −1.080 <.001*
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interaction effect observed, and the nature of this study in the specific context of a long-
term condition.
Our study suggests that loss-framed messages may be effective in situations beyond 
detection behaviours as previously suggested (O’Keefe & Jensen, 2009; Rothman et al., 
1999). Using this approach in people with psoriasis and greater CVD risk may encourage 
behaviour change but needs further testing beyond our initial findings.
There was a significant effect for message focus (psoriasis symptom reduction compared 
to CVD risk reduction) on emotional responses to information. Messages about CVD 
produced a higher emotional response compared to messages about psoriasis symptom 
reduction. This finding has important implications for how sensitive health information is 
delivered to patients (McBride et al., 2010).
We found no effect of message framing on behavioural intentions related to increasing 
physical activity or diet. Similar findings have been observed for physical activity and mak-
ing dietary changes (de Bruijn et al., 2014; van Assema et al., 2001), and health behaviours 
more generally (Avraham et al., 2016).
Implications for practice
Message framing has been examined in a range of behaviours (Abhyankar et al., 2008; 
Churchill et al., 2016; Morris et al., 2016; Pavey & Churchill, 2014; Updegraff et al., 2015), 
and now in a psoriasis population. We demonstrate a clear need for condition-specific 
health information for people with psoriasis (Keyworth, Nelson, Chew-Graham et al., 2015; 
Keyworth, Nelson, Griffiths et al., 2015; Nelson et al., 2017).
The precise reason for observing significant effects in changes to behavioural inten-
tions for reducing alcohol consumption must be examined in future research. However 
one hypothesis may be that in this population, the desire to reduce alcohol consumption 
outweighed all other health behaviours. One-third of our sample was exceeding recom-
mended guidelines for alcohol consumption, consistent with the psoriasis population gen-
erally (McAleer et al., 2011). High alcohol consumption is particularly problematic in this 
population (Parisi et al., 2017), and our results suggest some wish to make the necessary 
behavioural changes.
Risk category was a significant predictor of increased intentions for both alcohol 
reduction and increasing physical activity. People self-identifying as high risk according 
to their alcohol consumption or by not meeting guidelines for recommended activity 
reported greater intentions to modify their health behaviours. This illustrates the need 
for targeted health risk communication strategies. Psoriasis-specific information may 
increase message salience and facilitate cognitive processing (Kreuter et al., 1999; Latimer 
et al., 2005).
Based on our findings we recommend psoriasis-specific health messages that consider 
both the health behaviour being targeted and the message frame used. This will be more 
effective if done in a way that considers a range of psychological mechanisms involved in 
behaviour change, as communicating risk information alone may not be sufficient to induce 
sustained behaviour change (French et al., 2017). Finding new ways of communicating this 
information in a way that aids understanding and facilitates behaviour change can only 
serve to improve the clinical management of patients.
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Limitations
The low interaction effect observed in the context of alcohol reduction, and a lack of signif-
icant effects in further health behaviours, may be due to limitations in the specific measures 
used in the study. Validated measured for psoriasis populations would benefit from being 
sensitive to the known psychological impact of living with psoriasis (Kurd et al., 2010). The 
cross-sectional nature of the study limits our ability to assess the longer-term impact of 
appropriately framed health messages on behavioural intentions. Including a measure of 
self-reported behaviour in future studies would strengthen such conclusions. Additionally, 
the majority of participants in the study were recruited from the UK. Not all demographic 
information is available for the psoriasis population generally, and whilst we could not match 
population characteristics for psoriasis identically in terms of age and gender (Springate et 
al., 2017), alcohol intake closely resembled known levels of consumption (Parisi et al., 2017) 
with strengthens our hypotheses related to desire to intentions to reduce alcohol intake.
Conclusions
This is the first study to examine health risk communication, in the context of psoriasis, by 
investigating the role of message framing about future disease risk. For alcohol reduction, 
loss-framed messages appear to be more effective for CVD risk reduction information, 
and gain-framed messages are more effective for psoriasis symptom reduction informa-
tion. Messages about CVD result in higher emotional responses compared to messages 
about psoriasis symptom reduction. Taken together, our findings should be used to develop 
important health information for patients with psoriasis.
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